Bristol Myers Squibb (BMS) is a major global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases, particularly in areas like oncology, immunology, hematology, and cardiovascular conditions, with key products including Opdivo, Eliquis, and Revlimid, aiming to transform patient lives through science. Headquartered in Princeton, New Jersey, BMS has a significant global presence and invests heavily in research and development to address unmet medical needs.